Vaxil Bio Ltd. (TSXV:VXL)
Canada · Delayed Price · Currency is CAD 0.1800
-0.0150 (-7.69%)
At close: Jun 5, 2026
Vaxil Bio Market Cap
Vaxil Bio has a market cap or net worth of CAD 717.12 thousand as of June 26, 2026. Its market cap has decreased by -73.82% in one year.
Market Cap
717.12K
Enterprise Value
190.12K
Revenue
n/a
Ranking
n/a
PE Ratio
1.17
Stock Price
0.18
Market Cap Chart
Since March 10, 2016, Vaxil Bio's market cap has increased from 97.36K to 717.12K, an increase of 636.59%. That is a compound annual growth rate of 21.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 717.12K | 24.14% |
| Dec 30, 2025 | 577.68K | -83.13% |
| Dec 29, 2023 | 3.42M | 25.00% |
| Dec 30, 2022 | 2.74M | -73.33% |
| Dec 31, 2021 | 10.27M | -70.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioVaxys Technology | 3.09M |
| ASEP Medical Holdings | 2.06M |
| MindBio Therapeutics | 2.04M |
| Appili Therapeutics | 1.99M |
| Universal Ibogaine | 1.56M |
| Waverley Pharma | 1.35M |
| Doseology Sciences | 1.20M |
| ChitogenX | 415.65K |